Abstract:Xuefeng Rao Lihui Wan Zhigang Jie Xiaoliang Zhu Junxiang Yin Hong Cao 1Department of General Surgery, Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang 330006, People’s Republic of China; 2Department of Gastroenterology, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Nanchang 330006, People’s Republic of China; 3Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, People’s Republic of China Background: Abnormal miR-27a-3p expression has been frequently reported in several types of human cancer and contributes to tumor progression. However, the role and potential molecular mechanism of miR-27a-3p in the progression of pancreatic carcinoma have not been clarified. Materials and methods: The expression of miR-27a-3p and GATA binding protein 6 (GATA6) in pancreatic carcinoma tissues and cell lines was evaluated by quantitative realtime PCR and Western blotting analysis. The relationship between clinical pathologic features and miR-27a-3p expression was analyzed with Chi-square test. The regulatory mechanism of miR-27a-3p on GATA6 was confirmed by luciferase reporter assay and bioinformatics analysis. The effects of miR-27a-3p by targeting GATA6 on cell angiogenesis and migration were assessed by capillary tube formation and wound healing assays. Results: MiR-27a-3p expression was significantly upregulated in pancreatic carcinoma tissues and cell lines. Highly expressed miR-27a-3p was closely related to more lymph node metastasis, present peritoneal metastasis, and poor prognosis in patients with pancreatic carcinoma. MiR-27a-3p promoted migration and angiogenesis of pancreatic carcinoma cells by activating vascular endothelial growth factor A (VEGFA) and vascular endothelial growth factor receptor 2 (VEGFR2) expression. A significantly negative correlation between GATA6 mRNA and miR-27a-3 expression was found in pancreatic carcinoma samples. Modulation of miR-27a-3p could alter GATA6 expression in pancreatic carcinoma cells. GATA6 was identified as a functional target gene of miR-27a-3p, and GATA6 knockdown partially reversed the effects of miR-27a-3p siliencing on the migration and angiogenesis of pancreatic carcinoma cells by regulation of VEGFA/VEGFR2 pathway. Conclusion: Upregulated miR-27a-3p indicates a poor prognosis in pancreatic carcinoma patients and promotes the angiogenesis and migration by epigenetic silencing of GATA6 and activating VEGFA/VEGFR2 signaling pathway, and indicating miR-27a-3p may be a promising therapeutic target for pancreatic carcinoma treatment.

MicroRNA-494 Regulates Gli3 Expression and Inhibits Pancreatic Cancer Cells Growth and Migration

MicroRNA-204-3p Inhibits Metastasis of Pancreatic Cancer Via Downregulating MGAT1.

MicroRNA-509-3p Inhibits Cell Proliferation and Invasion Via Downregulation of X-linked Inhibitor of Apoptosis in Glioma.

Mir-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells

Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc.

MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1

MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3.

MiR-101-3p Inhibits EMT to Attenuate Proliferation and Metastasis in Glioblastoma by Targeting TRIM44

MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1R.

miR-509-5p inhibits cellular proliferation and migration via targeting MDM2 in pancreatic cancer cells.

MicroRNA-409-3p Represses Glioma Cell Invasion and Proliferation by Targeting High-Mobility Group Nucleosome-Binding Domain 5.

MicroRNA MiR-490-5p suppresses pancreatic cancer through regulating epithelial-mesenchymal transition via targeting MAGI2 antisense RNA 3

Microrna-497-5p Targeted Sox9 To Inhibit Proliferation, Migration And Invasion Of Glioma Cells

MiRNA203 Suppresses the Expression of Protumorigenic STAT1 in Glioblastoma to Inhibit Tumorigenesis

Identification of miR-6794-3p as a suppressor in pancreatic cancer metastasis

Upregulation of microRNA‑138‑5p inhibits pancreatic cancer cell migration and increases chemotherapy sensitivity

MiR-330-3p functions as a tumor suppressor that regulates glioma cell proliferation and migration by targeting CELF1

Mir-92B-3p Acts As a Tumor Suppressor by Targeting Gabra3 in Pancreatic Cancer.

Ott_a_220621 11241..11254

Mir-130b is A Prognostic Marker and Inhibits Cell Proliferation and Invasion in Pancreatic Cancer Through Targeting Stat3

MicroRNA-100 Regulates Pancreatic Cancer Cells Growth and Sensitivity to Chemotherapy Through Targeting FGFR3.